Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 288

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial

Open access
Gaudry, Stéphane, Hajage, David, Martin-Lefevre, Laurent, Lebbah, Saïd, Louis, Guillaume, Moschietto, Sébastien, Titeca-Beauport, Dimitri, Combe, Béatrice La, Pons, Bertrand, de Prost, Nicolas, Besset, Sébastien, Combes, Alain, Robine, Adrien, Beuzelin, Marion, Badie, Julio, Chevrel, Guillaume, Bohé, Julien, Coupez, Elisabeth, Chudeau, Nicolas, Barbar, Saber, Vinsonneau, Christophe, Forel, Jean-Marie, Thevenin, Didier, Boulet, Eric, Lakhal, Karim, Aissaoui, Nadia, Grange, Steven, Leone, Marc, Lacave, Guillaume, Nseir, Saad, Poirson, Florent, Mayaux, Julien, Asehnoune, Karim, Geri, Guillaume, Klouche, Kada, Thiery, Guillaume, Argaud, Laurent, Rozec, Bertrand, Cadoz, Cyril, Andreu, Pascal, Reignier, Jean, Ricard, Jean-Damien, Quenot, Jean-Pierre, Dreyfuss, Didier·2021·The Lancet

Abstract

BACKGROUND Delaying renal replacement therapy (RRT) for some time in critically ill patients with severe acute kidney injury and no severe complication is safe and allows optimisation of the use of medical devices. Major uncertainty remains concerning the duration for which RRT can be postponed without risk. Our aim was to test the hypothesis that a more-delayed initiation strategy would result in more RRT-free days, compared with a delayed strategy. METHODS This was an unmasked, multicentre, prospective, open-label, randomised, controlled trial done in 39 intensive care units in France. We monitored critically ill patients with severe acute kidney injury (defined as Kidney Disease: Improving Global Outcomes stage 3) until they had oliguria for more than 72 h or a blood urea nitrogen concentration higher than 112 mg/dL. Patients were then randomly assigned (1:1) to either a strategy (delayed strategy) in which RRT was started just after randomisation or to a more-delayed strategy. With the more-delayed strategy, RRT initiation was postponed until mandatory indication (noticeable hyperkalaemia or metabolic acidosis or pulmonary oedema) or until blood urea nitrogen concentration reached 140 mg/dL. The primary outcome was the number of days alive and free of RRT between randomisation and day 28 and was done in the intention-to-treat population. The study is registered with ClinicalTrial.gov, NCT03396757 and is completed. FINDINGS Between May 7, 2018, and Oct 11, 2019, of 5336 patients assessed, 278 patients underwent randomisation; 137 were assigned to the delayed strategy and 141 to the more-delayed strategy. The number of complications potentially related to acute kidney injury or to RRT were similar between groups. The median number of RRT-free days was 12 days (IQR 0-25) in the delayed strategy and 10 days (IQR 0-24) in the more-delayed strategy (p=0·93). In a multivariable analysis, the hazard ratio for death at 60 days was 1·65 (95% CI 1·09-2·50, p=0·018) with the more-delayed versus the delayed strategy. The number of complications potentially related to acute kidney injury or renal replacement therapy did not differ between groups. INTERPRETATION In severe acute kidney injury patients with oliguria for more than 72 h or blood urea nitrogen concentration higher than 112 mg/dL and no severe complication that would mandate immediate RRT, longer postponing of RRT initiation did not confer additional benefit and was associated with potential harm. FUNDING Programme Hospitalier de Recherche Clinique.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(21)00350-0

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 288

Metadata

Authors
Gaudry, S., Hajage, D., Martin-Lefevre, L., Lebbah, S., Louis, G., Moschietto, S., Titeca-Beauport, D., Combe, B. L., Pons, B., de Prost, N., Besset, S., Combes, A., Robine, A., Beuzelin, M., Badie, J., Chevrel, G., Bohé, J., Coupez, E., Chudeau, N., Barbar, S., Vinsonneau, C., Forel, J.-M., Thevenin, D., Boulet, E., Lakhal, K., Aissaoui, N., Grange, S., Leone, M., Lacave, G., Nseir, S., Poirson, F., Mayaux, J., Asehnoune, K., Geri, G., Klouche, K., Thiery, G., Argaud, L., Rozec, B., Cadoz, C., Andreu, P., Reignier, J., Ricard, J.-D., Quenot, J.-P., & Dreyfuss, D.
Venue
The Lancet
Publisher
Elsevier BV
Published
2021-04
Volume
397
Issue
10281
Pages
1293-1300
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W3139812053
Cited by
288
References
23
FWCI
20.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(21)00350-0
The paper
Gaudry, S., Hajage, D., Martin-Lefevre, L., Lebbah, S., Louis, G., Moschietto, S., Titeca-Beauport, D., Combe, B. L., Pons, B., de Prost, N., Besset, S., Combes, A., Robine, A., Beuzelin, M., Badie, J., Chevrel, G., Bohé, J., Coupez, E., Chudeau, N., . . . Dreyfuss, D. (2021). Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(21)00350-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.